Artiman Ventures: Investor Profile

Artiman Ventures is a Silicon Valley and Bengaluru early-stage venture fund with over $1 billion under management, as reported by Inc42. Founded in 2001 by entrepreneurs-turned-investors, the firm operates out of Palo Alto and Bangalore and has backed more than 100 companies across its history, according to a 2026 investor profile on YesPress. It is best known for chasing 'white space' investments: startups with no identifiable competitors that have the potential to create or disrupt multi-billion-dollar markets.

For Indian founders, Artiman's dual geography is the point. The firm has long run a Bengaluru presence, at the Hulkul Centre, and has actively evaluated Indian deep-tech pitches. Inc42 reported in 2017 that eight of its portfolio companies at the time were Indian, a share the firm said it wanted to grow as India's deep-tech talent pool matured.

Investment thesis and focus

Artiman is deliberately sector-agnostic and trans-disciplinary. The firm describes its sweet spot as disruptive technologies at the intersection of multiple markets or technologies, with Artiman typically the first institutional capital in, often at the concept phase. Its investment areas span AI, cybersecurity, enterprise software, healthcare diagnostics and medtech, semiconductors, and digital health.

Partner Ramesh Radhakrishnan told Inc42 the team looks for startups that could either disrupt an existing market and create their own or provide a platform that finds applications across verticals. The firm's own positioning is that every partner has first built and run companies, so it brings empathy, curiosity and operational experience alongside capital.

Fund and stage

Artiman invests from seed through early growth, usually leading or co-leading. According to Inc42, the firm's total corpus stood at $1.1 billion, deployed through early-stage vehicles including Artiman Ventures III, a $200 million fund closed in 2010. Gaebler's VC database also records a $133 million Artiman Ventures Special Opportunities Fund (2011) and earlier funds of $181.39 million and $160 million. The firm typically invests $2-6 million in its first cheque and up to $8-25 million over a company's life, per MassInvestor data.

Portfolio highlights

The firm has logged 14 IPOs and two unicorns over its history, per the YesPress profile. Notable exits include SigmaTel (Nasdaq: SGTL), BioImagene (acquired by Roche), Matrix Semiconductor (acquired by SanDisk), VxTel (acquired by Intel), LogLogic (acquired by TIBCO) and Validity (acquired by Synaptics).

Current investments showcased on its website include Niron Magnetics (rare-earth-free magnets), Tonbo Imaging (electro-optics and embedded vision for defence), ApplyBoard (AI-enabled marketplace for international students), Virsec (application attack detection and prevention), CellMax Life (precision cancer blood testing) and Visby Medical (rapid disease diagnostics).

People and how to reach them

The partner team includes Yatin Mundkur (General Partner, Palo Alto), Ramesh Radhakrishnan, Amit Shah, Ajit Singh, Brian Wilcove and Tim Wilson, with Akhil Saklecha recorded as a founding partner. The firm is a member of the National Venture Capital Association and keeps a notably low media profile compared with its capital base.